Grannus Therapeutics
Plug and Play · Grannus Therapeutics is a preclinical biotech startup, focused on developing novel first-in-class Hsp90𝛽-selective inhibitors for the treatment of multiple solid tumors.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 Eris BiotechShared: solid tumor, small molecule, therapeuticActiveOther | Other | Active | YCW24 |
 Gerostate AlphaShared: developing novel, therapeuticInactiveOther | Other | Inactive | YCS18 |
 Encepheal TherapeuticsShared: small molecule, inhibitor, therapeuticInactiveOther | Other | Inactive | YCS19 |
 Sift BiosciencesShared: solid tumor, class, novelNot statedOther | Other | Not stated | Plug and Play |
 Scioto BiosciencesShared: developing innovative, preclinical, therapeuticNot statedOther | Other | Not stated | Plug and Play |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 Origami Therapeutics, Inc.Shared: developing novel, small molecule, therapeuticActiveOther | Other | Active | YCW22 |
| ShasqiShared: cancer treatment, tumor, therapeuticActiveAI | AI | Active | YCW15 |
 Bahto BiosciencesShared: small molecule, therapeutic, treatmentNot statedOther | Other | Not stated | Plug and Play |
 AlixiaShared: cancer treatment, tumor, multipleActiveOther | Other | Active | YCW22 |
 Gelsana Therapeutics, Inc.Shared: therapeutic aims, developing innovative, novelNot statedOther | Other | Not stated | Plug and Play |
Also from Plug and Play
All of Plug and Play
Programs
| Program | Cohort | Source |
|---|---|---|
 Plug and Play | Not stated | Plug and Play Page |
About Grannus Therapeutics
"Grannus Therapeutics is a pioneering lifetech startup dedicated to developing innovative Hsp90β-selective inhibitors for the treatment of multiple solid tumors. By focusing on a specific isoform of the Hsp90 chaperone protein, Grannus Therapeutics aims to overcome the toxicity challenges faced by previous pan-inhibitors, leading to more effective and targeted cancer treatments. Their pipeline of first-in-class small molecule inhibitors is designed to deliver potent anti-tumor efficacy without the dose-limiting side effects associated with traditional Hsp90 inhibitors. These compounds show promise in treating various solid tumors, including ovarian, triple-negative breast, prostate, and pancreatic cancers. With the potential for combination therapies with existing cancer treatments, such as chemotherapy and PARP inhibitors, Grannus Therapeutics is at the forefront of advancing oncology research and improving patient outcomes."
- Category
- Other
- Location
- United States
- Checked
- 2h ago
Grannus Therapeutics: questions
Which accelerators did Grannus Therapeutics go through?
Grannus Therapeutics is listed by Plug and Play.
Where is Grannus Therapeutics based?
Grannus Therapeutics lists United States as its location on Plug and Play's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.